Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older.
- People who are able to attend all required study visits and follow the study schedule.
- People who have been diagnosed with primary open-angle glaucoma (including normal tension or low tension types), with vision test results falling within a specific range of severity — not too mild and not too advanced — as measured by a standard visual field test called Humphrey Visual Field 24-2.
- People whose eye pressure is stable and measures below 18 on standard eye pressure testing.
- People with two eyes that both meet the study requirements — in that case, the eye with the worse visual field score would be the one entered into the study, or the person may choose, or a random assignment process may be used.
- People who are able to read and sign a consent form, or who can have the consent form read aloud to them if their vision makes reading difficult.
Who may not be able to join:
- People who are unable to follow the study procedures or attend follow-up visits.
- People who have a history of eye herpes zoster (a viral infection affecting the eye).
- People who are currently taking or need to take acyclovir or related antiviral medications during the study period.
- People who have cloudiness or reduced clarity of the cornea (the front surface of the eye).
- People who have uveitis or other inflammatory conditions affecting the eye.
- People who are taking steroid medications or other medicines that suppress the immune system.
- People who are currently in another clinical drug trial, or who have been in one in the past 3 months (either eye drops in the study eye or medications taken by mouth or injection).
- People who are pregnant or breastfeeding.
- People who have a physical or mental health condition that, in the opinion of the study doctor, could increase the risk of taking part or interfere with study results.
- People who have an opening in the skull, have had a trepanation procedure, or have a heart or brain pacemaker.
- People who have metal implants inside the skull, such as surgical clips, coils, brain fluid shunts, or similar devices.
- People who have any skin damage in the area where study electrodes would be placed.
- People who are under 18 or who are in a coma.
- People who have recently had an epileptic seizure.
- People with uncontrolled high blood pressure (above 160 mmHg) or uncontrolled high eye pressure (above 27 mmHg).
- People with a current problem with drug or alcohol misuse.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jeffrey L Goldberg, MD PhD, Stanford University
Phone: 650-497-5942
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Visual Field Index (VFI); Mean Deviation (MD); Pointwise Linear Regression (PLR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.